Kozak & Associates »

Vivos Therapeutics shares owned by Kozak & Associates

Quarter-by-quarter ownership of Vivos Therapeutics (VVOS) shares owned by Kozak & Associates from 13F filings

Historical chart of Kozak & Associates investment in Vivos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vivos Therapeutics held by Kozak & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vivos Therapeutics by Kozak & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $351 49 7.16

More positions owned by Kozak & Associates

Spdr S&p 500 Etf Trust Etf (SPY)
Ishares U.s. Tech Independence Focused Etf Etf (IETC)
Invesco Qqq Trust Series I Etf (QQQ)
Invesco S&p 500 Revenue Etf Etf (RWL)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Ishares Us Financial Services Etf Etf (IYG)
Nvidia Corporation Stock (NVDA)
Costco Whsl Corp Stock (COST)
Amazon Stock (AMZN)
Health Care Select Sector Spdr Fund Etf (XLV)
Vaneck Semiconductor Etf Etf (SMH)
Schwab Charles Corp Stock (SCHW)
Deere & Co Stock (DE)

View all positions for Kozak & Associates

Top funds holding Vivos Therapeutics

Strategic Wealth Designers
Schonfeld Strategic Advisors
Commonwealth Equity Services
Vanguard Group
Newbridge Financial Services Group
Signature
Kozak & Associates
Global Retirement Partners
Steward Partners Investment Advisory
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Vivos Therapeutics